上海研盟生物有限公司*品質(zhì)供應(yīng)Anti-Acid sphingomyelinase抗體，我公司銷售國內(nèi)外科研產(chǎn)品，如生物試劑、生化試劑，一抗二抗，各種標記抗體，Elisa酶聯(lián)免疫試劑盒，放免試劑盒，培養(yǎng)基，各種動物血清等產(chǎn)品，歡迎廣大新老客戶前來咨詢訂購，訂購:或。

酸性神經(jīng)鞘磷脂酶抗體,Anti-Acid sphingomyelinase抗體簡單介紹：

中文名稱：酸性神經(jīng)鞘磷脂酶抗體

英文名稱：Anti-Acid sphingomyelinase抗體

別 名：Acid sphingomyelinase; ASM; ASM_HUMAN; aSMase; NPD; Smpd1; Sphingomyelin phosphodiesterase 1 acid lysosomal; Sphingomyelin phosphodiesterase.  

此產(chǎn)品本公司有標記的一抗出售，相關(guān)標記有：Alexa Fluor 350 標記、Alexa Fluor 488 標記、Alexa Fluor 555 標記、Alexa Fluor 647 標記、AP標記、APC標記、Biotin標記、Cy3標記、Cy5標記、Cy5.5標記、Cy7標記、FITC標記、Gold標記、HRP標記、PE標記、PE-Cy3標記、PE-CY5標記、PE-CY5.5標記、PE-CY7標記、RBITC標記

背景介紹：Converts sphingomyelin to ceramide. Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol. Isoform 2 and isoform 3 have lost catalytic activity.
Involvement in disease: Defects in SMPD1 are the cause of Niemann-Pick disease type A (NPDA) ; also known as Niemann-Pick disease classical infantile form. It is an early-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Niemann-Pick disease type A is a primarily neurodegenerative disorder characterized by onset within the first year of life, mental retardation, digestive disorders, failure to thrive, major hepatosplenomegaly, and severe neurologic symptoms. The severe neurological disorders and pulmonary infections lead to an early death, often around the age of four. Clinical features are variable. A phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B.

規(guī)格：0.1ml/0.2ml

濃度：1mg/1ml

抗體來源：本公司抗體有兔來源和鼠來源等

克隆類型：兔來源為多抗，鼠來源為單抗

產(chǎn)品類型：一抗

酸性神經(jīng)鞘磷脂酶抗體保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

避免反復(fù)凍融，保質(zhì)期一年。

酸性神經(jīng)鞘磷脂酶抗體,Anti-Acid sphingomyelinase抗體免疫組化問題解答

1、染色過強？

原 因：抗體濃度過高或孵育時間過長

解決方法：降低抗體滴度、抗體孵育時間：室溫1小時或4度過夜

原 因：孵育溫度過高超過37度

解決方法：一般在室溫20-28度

原 因：DAB顯色時間過長或濃度過高

解決方法：顯色時間不超過5-12分鐘，以顯微鏡下觀察為準

2、非特異性背景染色？

原 因：操作過程中沖洗不充分

解決方法：每步?jīng)_洗3次每次5分鐘

原 因：組織中含過氧化物酶未阻斷

解決方法：可再配置新鮮3%H2O2封閉孵育時間延長

原 因：組織中含內(nèi)原性*

解決方法：正常非免疫動物血清再封閉

原 因：血清蛋白封閉不充分

解決方法：血清蛋白封閉不充分

相關(guān)優(yōu)質(zhì)產(chǎn)品：

SSTR1 (somatostatin receptor 1)  *受體1(SSTR1)抗體
SSTR2 (somatostatin receptor 2)  *受體2抗體
SSTR3 (somatostatin receptor 3)  *受體3抗體
SSTR4(somatostatin receptor 4)  *受體4抗體
SSTR5 (somatostatin receptor 5)  *受體5抗體
STAT1（signal transduceBYK and activatoBYK of transcription 1）  信號轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1抗體
phospho-STAT1(p-Tyr701)  抗磷酸化信號轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1抗體
STAT2 (signal transduceBYK and activatoBYK of transduction2)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子2(STAT2)抗體
STEAP1（Six transmbrane epithelial antigen of the prostate 1）  前列腺跨膜上皮1抗原抗體
phospho-STAT3(pThr705)  抗磷酸化信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3抗體
phospho-STAT5a(pThr694)  抗磷酸化信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子5a抗體
phospho-STAT6(pThr641)  抗磷酸化信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗體
STAT3 (signal transduceBYK and activatoBYK of transduction 3)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3抗體
STAT4 (signal transduceBYK and activatoBYK of transduction 4)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子4抗體
STAT5 (signal transduceBYK and activatoBYK of transduction 5)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子5(STAT5)抗體
STAT6 (signal transduceBYK and activatoBYK of transduction 6)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗體
Stra8(Stimulated by retinoic acid gene 8)  *激活基因8抗體
STRO-1  一種間充質(zhì)干細胞抗體
streptomycin  *抗體